Agenus Inc Stock Price on December 3, 2024
| AGEN Stock | USD 3.12 0.28 8.24% |
If you're considering investing in Agenus Stock, it is important to understand the factors that can impact its price. As of today, the current price of Agenus stands at 3.12, as last reported on the 13th of January 2025, with the highest price reaching 3.46 and the lowest price hitting 3.05 during the day. Agenus Inc secures Sharpe Ratio (or Efficiency) of -0.0873, which signifies that the company had a -0.0873% return per unit of standard deviation over the last 3 months. Agenus Inc exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Agenus' mean deviation of 3.98, and Risk Adjusted Performance of (0.06) to double-check the risk estimate we provide.
Agenus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Agenus |
Sharpe Ratio = -0.0873
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AGEN |
Estimated Market Risk
| 5.73 actual daily | 51 51% of assets are less volatile |
Expected Return
| -0.5 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Agenus is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Agenus by adding Agenus to a well-diversified portfolio.
Related Headline
X4 Pharmaceuticals Headline on 3rd of December 2024
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq ... by finance.yahoo.com
BOSTON, Dec. 03, 2024 -- X4 Pharmaceuticals , a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on December 2, 2024, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan . The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employ
Agenus Valuation on December 3, 2024
It is possible to determine the worth of Agenus on a given historical date. On December 3, 2024 Agenus was worth 3.7 at the beginning of the trading date compared to the closed value of 3.5. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Agenus stock. Still, in general, we apply an absolute valuation method to find Agenus' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Agenus where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Agenus' related companies.
| Open | High | Low | Close | Volume | |
| 3.45 | 3.74 | 3.35 | 3.73 | 660,864 | |
12/03/2024 | 3.70 | 3.73 | 3.46 | 3.50 | 795,954 |
| 3.53 | 3.75 | 3.43 | 3.43 | 640,243 |
| Backtest Agenus | | | Agenus History | | | Agenus Valuation | Previous | Next |
Agenus Trading Date Momentum on December 3, 2024
| On December 04 2024 Agenus Inc was traded for 3.43 at the closing time. The top price for the day was 3.75 and the lowest listed price was 3.43 . The trading volume for the day was 640.2 K. The trading history from December 4, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.00% . The overall trading delta against the current closing price is 11.43% . |
Agenus Inc Fundamentals Correlations and Trends
By evaluating Agenus' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Agenus' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Agenus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Agenus Stock history
Agenus investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Agenus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Agenus Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Agenus stock prices may prove useful in developing a viable investing in Agenus
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts. Agenus operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 441 people.
Agenus Stock Technical Analysis
Agenus technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Agenus Period Price Range
Low | January 13, 2025
| High |
0.00 | 0.00 |
Agenus Inc cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Agenus January 13, 2025 Market Strength
Market strength indicators help investors to evaluate how Agenus stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Agenus shares will generate the highest return on investment. By undertsting and applying Agenus stock market strength indicators, traders can identify Agenus Inc entry and exit signals to maximize returns
Agenus Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Agenus' price direction in advance. Along with the technical and fundamental analysis of Agenus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Agenus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.52) | |||
| Total Risk Alpha | (0.43) | |||
| Treynor Ratio | 1.29 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.